Compare DXR & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DXR | NMS |
|---|---|---|
| Founded | 1970 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.0M | 63.1M |
| IPO Year | 1995 | 2014 |
| Metric | DXR | NMS |
|---|---|---|
| Price | $10.05 | $10.28 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 15.0K | ★ 28.7K |
| Earning Date | 11-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.11% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $1,446,345.00 | N/A |
| Revenue This Year | $44,489.33 | N/A |
| Revenue Next Year | $74.79 | N/A |
| P/E Ratio | $33.83 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.56 | $9.48 |
| 52 Week High | $14.76 | $12.50 |
| Indicator | DXR | NMS |
|---|---|---|
| Relative Strength Index (RSI) | 39.18 | 53.30 |
| Support Level | $9.38 | $9.48 |
| Resistance Level | $10.99 | $12.48 |
| Average True Range (ATR) | 0.49 | 0.19 |
| MACD | -0.10 | 0.09 |
| Stochastic Oscillator | 5.24 | 92.50 |
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The company has Single operating segment.